November 2, 2021
PAR-22-049 - Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed)
National Cancer Institute (NCI)
This Notice corrects the expiration date for Funding Opportunity Announcement (FOA) PAR-22-049, "Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed)".
The following modification has been made to PAR-22-049 to reflect the corrected expiration date:
Currently Reads:
Part 1. Overview Information
Key Dates
Expiration Date: September 14, 2023
Modified to Read (change shown in bold italics):
Part 1. Overview Information
Key Dates
Expiration Date: September 14, 2024
All other aspects of this FOA remain unchanged.
Scientific/Research Contact(s)
Lokesh Agrawal, PhD
National Cancer Institute (NCI)
Telephone:240-276-5718
Email: lokesh.agrawal@nih.gov
Abhi Rao, PhD
National Cancer Institute (NCI)
Telephone: 240-276-5715
Email: abhi.rao@nih.gov
Peer Review Contact(s)
Referral Officer
National Cancer Institute (NCI)
Telephone: 240-276-6390
Email: ncirefof@dea.nci.nih.gov
Financial/Grants Management Contact(s)
Shane Woodward
National Cancer Institute (NCI)
Telephone: 240-276-6303
Email: Shane.Woodward@nih.gov